Pharma giant GSK woos President Trump with $30 billion investment Pharmaceuticals September 17, 2025 GSK commits $30 billion investment in U.S. R&D and manufacturing during Trump’s UK state visit, strengthening its focus on innovation-driven biopharmaceutical growth.